It’s an unfortunate fact: Too many Americans don’t get enough sleep.
The National Sleep Foundation recommends that adults get between 7-9 hrs. of sleep each night. However, per the Centers for Disease Control and Prevention, between 50 and 70 million U.S. adults have a sleep or wakefulness disorder. This is considered a public health problem, as a lack of sleep is linked to an increase in car accidents, industrial disasters, and medical and other occupational errors.
Insomnia can occur over one night or stretch over weeks, months, or even years. It may be caused by many things, such as psychiatric or medical conditions, unhealthy sleep habits, specific substances, and/or certain biological factors. Inadequate sleep can result in a multitude of negative outcomes, including depression, diabetes, obesity, hypertension, stroke and heart attack.
In recent years, there have been many well executed studies that look at the cost insomnia has on our society.
A 2011 study lead by Ronald C. Kessler, Ph.D., revealed that nearly a quarter of all workers are affected by sleeplessness. And insomnia costs an average of $2,280 per worker in reduced productivity every year which equates to a total cost of $63.2 billion to the economy, the study showed. “That equates to 11 working days lost annually for each worker,” said Dr. Kessler.
In another study, Dr. Khaled Sarsour and colleagues examined data from a survey of 2,086 patients in an insurance database. These participants were then matched with non-insomnia controls. The investigators found the overall costs for people with moderate-severe insomnia were significantly higher than those of the non-insomnia controls ($1,323 vs $757). And, costs due to a loss of productivity were also much higher with people who had moderate-severe insomnia verses the controls ($1,739 vs $1,013).
Patients with insomnia frequently have a higher rate of psychiatric and medical conditions, consume more healthcare services, are less productive in the workplace, utilize a greater amount of healthcare service and are have a higher risk of being involved in severe accidents than those who do not have insomnia.
The key point is that insomnia is a major public health problem, with tremendous health and economic consequences. The good news is, that although insomnia continues to be woefully widespread in our society, new drugs are being developed to help manage and potentially treat this condition. With ongoing research and clinical trials, newer drugs that can help to effectively treat insomnia can be identified.
Meridien Research has successfully lead numerous clinical research trials for insomnia. If you would like more information about the studies at Meridien Research, please call 888-777-8839, or submit an inquiry to email@example.com..